Navigation Links
Spectral announces 2007 financial results
Date:3/7/2008

TORONTO, March 7 /PRNewswire-FirstCall/ - Spectral Diagnostics Inc. (TSX:SDI) today announced its operational highlights and financial results for the fiscal year ended December 31, 2007.

"Spectral's priority is the commercialization of its EAA(TM) Endotoxin Activity Assay, the only FDA cleared assay for the measurement of endotoxin. Endotoxemia is a systemic response to bacterial toxins that can rapidly lead to organ dysfunction, septic shock and ultimately death. Healthcare professionals have become much more aware of endotoxemia over the last several years, and many of the emerging therapies for sepsis now advancing though clinical trials target endotoxin," said Dr. Paul Walker, President and CEO of Spectral Diagnostics. "The growing awareness of endotoxemia, and the increasing number of therapies being developed for this indication, position us well to drive adoption of the EAA(TM), which can be used to identify patients, enable therapeutics and monitor treatment."

Highlights from 2007:

- Entered into an exclusive agreement in November 2007 with Toray

Medical Co. Ltd. to distribute Spectral's EAA(TM) Endotoxin Activity

Assay in Japan. Toray Medical will market and sell the EAA(TM) in

conjunction with its Toraymyxin blood purification device, which

removes endotoxin from the bloodstream. Toray Medical will also

distribute the EAA(TM) diagnostic as a stand-alone product.

- Launched the EAA(TM) in Germany in September 2007 through A. Menarini

Diagnostics Deutschland, building on a distribution agreement signed

in May 2007 which covers Germany and includes an option to extend the

arrangement to the rest of Europe.

- Expanded its EAA(TM) product distribution agreement in Italy with its

partner Estor, SpA in May 2007. The expanded agreement is aimed at

increasing the number of hospitals in Italy utilizing the EAA(TM)

as
'/>"/>

SOURCE Spectral Diagnostics Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Spectral partner launches EAA(TM) Rapid Sepsis Diagnostic in Germany
2. US Patent and Trademark Office Allows CRis Patent Application for Spectral Imaging of Deep Tissue
3. CRi Announces Nuance 2, the Next-Generation Multispectral Imaging System for Brightfield and Fluorescent-Based Microscopy
4. Spectral announces data on the clinical utility of EAA(TM) to be presented at 12th Annual Critical Care for Endotoxemia Conference in Japan
5. Spectral appoints Anthony Bihl to Board of Directors
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... The JM Internet Group (web: jm-seo.org), a ... announced that the company's YouTube channel on SEO ... on YouTube. The company uses YouTube as a way ... training for small businesses with much success. , "I ... helpful for their SEO strategies", explained Jason McDonald, director ...
(Date:5/17/2013)... news release is available in German . ... too well: with the naked eye, you can see which ... in the blur of branches through the telephoto lens for ... for researchers who are looking to study proteins, the active ... ETH Zurich,s Institute for Molecular Systems Biology, and her colleagues ...
(Date:5/17/2013)... , May 17, 2013  Cellular Biomedicine ... achieved 50% enrollment of the total projected enrollment ... the safety and preliminary efficacy of the medical ... for Knee Osteoarthritis (KOA). To date the trial ... The Phase I open label clinical ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 The paradigm ... complex biological systems that can help predict the adverse ... Dr. Sergey Stepaniants, Head of Computational Biology at the ... biology tools to ensure high-quality genomics when used as ... be applied to complex data sets to identify key ...
Breaking Biology Technology:YouTube Channel on SEO Tips Surpasses 175,000 Views, Announces JM Internet Group 2Proteome atlas for the tuberculosis pathogen 2Proteome atlas for the tuberculosis pathogen 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2
... and TORONTO, Nov. 13 /PRNewswire/ - BioRelix, ... based therapeutic agents and,Dalton Medicinal Chemistry, have ... therapeutics. Dalton Medicinal Chemistry will utilize ... novel classes of compounds against selected,RiboSwitch targets. ...
... Patients suffering from a range of debilitating illnesses, such as ... and ataxia stand to benefit from a new laboratory, established, ... China at the,forefront of the global race to engineer and reprogram ... ...
... Equity Research, Inc.,(Scimitar) issues a review of Neurobiological ... Viprinex(TM) Mission by a,Successful $60m Offering; Mountains Do ... website: http://www.scimitarequity.com . Neurobiological Technologies, Inc. ... of acquiring and developing central nervous system,related drug ...
Cached Biology Technology:BioRelix and Dalton Medicinal Chemistry Sign Research Agreement to Capitalize on RiboSwitch Technology 2Stem Cell Leader Beike Biotech and China's Tsinghua University Receive US$4 Million for Stem Cell Reprogramming Laboratory 2Stem Cell Leader Beike Biotech and China's Tsinghua University Receive US$4 Million for Stem Cell Reprogramming Laboratory 3Stem Cell Leader Beike Biotech and China's Tsinghua University Receive US$4 Million for Stem Cell Reprogramming Laboratory 4Neurobiological Technologies, Inc. (Nasdaq: NTII) Q1/08 Review Issued By Scimitar Equity Research, Inc. 2
(Date:5/16/2013)... scientist has discovered an ancient extinct creature with ,scissor ... in honour of his favourite movie star. , ... deppi (pronounced Koo-ten-ee-che-la depp-eye), which is a distant ... actor Johnny Depp for his starring role as Edward ... Edward, an unfinished creation, who has scissors for hands. ...
(Date:5/16/2013)... world are meeting next week in Toronto. The ... latest in research findings about the brain, the ... disorders that affect them., "Canada is a leader ... the best of neuroscience research done here and ... the Canadian Association for Neuroscience. He also reminds ...
(Date:5/16/2013)... -- The consultancy Frost & Sullivan presented ... Germany,s largest biometrics manufacturer, DERMALOG Identification ... DERMALOG has been honored yesterday night by Frost ... category Global Biometrics and Border Control  Customer Value Enhancement ... Control System . One of the decisive factors in ...
Breaking Biology News(10 mins):Actor Johnny Depp immortalized in ancient fossil find 27th Annual Canadian Neuroscience Meeting, Toronto, May 20-24, 2013 2Global Biometrics and Border Control Award for DERMALOG 2Global Biometrics and Border Control Award for DERMALOG 3Global Biometrics and Border Control Award for DERMALOG 4
... Development, Dr. Mary Ellen Perry and colleagues validate the ... therapies. , The p53 tumor suppressor plays a critical ... to activate p53 in order to curb tumor formation. ... an attractive target to modulate p53 activity in cells. ...
... Prostaglandins ?the fat-derived compounds linked to pain, inflammation, ... to their extensive catalog. , A new study ... the intricate cell movements during early embryonic development ... might influence human development and the spread of ...
... With an equal rate of incidence and mortality-the number of ... die from it-Glioblastoma Multiforme (GBM) is a brain cancer death ... with GBM annually in the U.S., half will die within ... only treatments that stretch survival limits are exceptionally invasive surgeries ...
Cached Biology News:Study fishes out new role for prostaglandins 2Study fishes out new role for prostaglandins 3Radiotherapy advance points way to noninvasive brain cancer treatment 2Radiotherapy advance points way to noninvasive brain cancer treatment 3
Goat polyclonal to Lipocalin 2...
Human GCP-2 is a member of the CXC family of chemokines. It also promotes neutrophil chemotaxis and deganulation. GF063 is an 8.0 kDa protein containing 73 amino acid residues....
... Anti-Matrix Metalloproteinase-2, Hinge Region By immunoblotting ... native protein. It reacts with free MMP-2 ... antibody buffered aqueous glycerol solution ... pH 7.4, containing 50% glycerol and 15 ...
human Exodus-2 Research Focus: cytokine/growth factor Storage Temperature: -20C Shipping Temperature: 4C...
Biology Products: